Cargando…
4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two.
OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening...
Autores principales: | , , , , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Cambridge University Press
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822913/ http://dx.doi.org/10.1017/cts.2020.170 |
_version_ | 1784646701524451328 |
---|---|
author | Failla, Michelle D Schwartz, Kyle Chaganti, Shikha Woynaroski, Tiffany G Cutting, Laurie Landman, Bennett Cascio, Carissa |
author_facet | Failla, Michelle D Schwartz, Kyle Chaganti, Shikha Woynaroski, Tiffany G Cutting, Laurie Landman, Bennett Cascio, Carissa |
author_sort | Failla, Michelle D |
collection | PubMed |
description | OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening practices. METHODS/STUDY POPULATION: We used electronic health record data from an anonymized database at Vanderbilt University Medical Center for individuals with ASD and matched controls to analyze comorbid conditions prior to an ASD diagnosis. Data were censored to include only individuals who first appeared in the databank prior to two years of age (n(total) = 1551, n(controls) = 976, n(ASD) = 575). Comorbidities (~1800 conditions) were compared between the ASD and matched control group using a novel tool (pyPheWAS) to examine presence, count, and duration of comorbidities that occurred between 0-2 years old and before ASD diagnosis. RESULTS/ANTICIPATED RESULTS: Convulsions (p = 0.000404, ß = 0.807), constipation (p = 0.000789, ß = 0.894), and strabismus (p = 0.00243, ß = 1.155) were the most significant comorbid conditions prior to age 2 in individuals who would later be diagnosed with ASD. The group with ASD also had more visits associated with convulsions (p = 0.00511, ß = 0.195), diseases of the esophagus (p = 0.0117, ß = 1.675), and allergic reactions to food (p = 0.0119, ß = 0.540) prior to their diagnosis. The ASD group was also seen for a longer duration regarding convulsions (p = 0.000273, ß = 0.695), constipation (p = 0.00157, ß = 0.712), and malaise and fatigue (p = 0.00188, ß = 0.903) before ASD diagnosis. DISCUSSION/SIGNIFICANCE OF IMPACT: Precise comorbid condition profiles in early childhood may help uncover biomarkers leading to better prediction of a future ASD diagnosis. Medical conditions that precede the onset of measurable behavioral symptoms may enhance early screening, treatment, and intervention in ASD. |
format | Online Article Text |
id | pubmed-8822913 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2020 |
publisher | Cambridge University Press |
record_format | MEDLINE/PubMed |
spelling | pubmed-88229132022-02-18 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. Failla, Michelle D Schwartz, Kyle Chaganti, Shikha Woynaroski, Tiffany G Cutting, Laurie Landman, Bennett Cascio, Carissa J Clin Transl Sci Data Science/Biostatistics/Informatics OBJECTIVES/GOALS: Autism spectrum disorder (ASD) is a developmental disorder with a high financial and personal burden. Individuals with ASD experience significant comorbid medical conditions. We identified conditions that appear prior to ASD diagnosis in order to potentially improve early screening practices. METHODS/STUDY POPULATION: We used electronic health record data from an anonymized database at Vanderbilt University Medical Center for individuals with ASD and matched controls to analyze comorbid conditions prior to an ASD diagnosis. Data were censored to include only individuals who first appeared in the databank prior to two years of age (n(total) = 1551, n(controls) = 976, n(ASD) = 575). Comorbidities (~1800 conditions) were compared between the ASD and matched control group using a novel tool (pyPheWAS) to examine presence, count, and duration of comorbidities that occurred between 0-2 years old and before ASD diagnosis. RESULTS/ANTICIPATED RESULTS: Convulsions (p = 0.000404, ß = 0.807), constipation (p = 0.000789, ß = 0.894), and strabismus (p = 0.00243, ß = 1.155) were the most significant comorbid conditions prior to age 2 in individuals who would later be diagnosed with ASD. The group with ASD also had more visits associated with convulsions (p = 0.00511, ß = 0.195), diseases of the esophagus (p = 0.0117, ß = 1.675), and allergic reactions to food (p = 0.0119, ß = 0.540) prior to their diagnosis. The ASD group was also seen for a longer duration regarding convulsions (p = 0.000273, ß = 0.695), constipation (p = 0.00157, ß = 0.712), and malaise and fatigue (p = 0.00188, ß = 0.903) before ASD diagnosis. DISCUSSION/SIGNIFICANCE OF IMPACT: Precise comorbid condition profiles in early childhood may help uncover biomarkers leading to better prediction of a future ASD diagnosis. Medical conditions that precede the onset of measurable behavioral symptoms may enhance early screening, treatment, and intervention in ASD. Cambridge University Press 2020-07-29 /pmc/articles/PMC8822913/ http://dx.doi.org/10.1017/cts.2020.170 Text en © The Association for Clinical and Translational Science 2020 https://creativecommons.org/licenses/by/4.0/This is an Open Access article, distributed under the terms of the Creative Commons Attribution licence (http://creativecommons.org/licenses/by/4.0/), which permits unrestricted re-use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Data Science/Biostatistics/Informatics Failla, Michelle D Schwartz, Kyle Chaganti, Shikha Woynaroski, Tiffany G Cutting, Laurie Landman, Bennett Cascio, Carissa 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title | 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title_full | 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title_fullStr | 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title_full_unstemmed | 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title_short | 4420 Characterizing medical comorbidity prior to autism diagnosis in children before age two. |
title_sort | 4420 characterizing medical comorbidity prior to autism diagnosis in children before age two. |
topic | Data Science/Biostatistics/Informatics |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8822913/ http://dx.doi.org/10.1017/cts.2020.170 |
work_keys_str_mv | AT faillamichelled 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT schwartzkyle 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT chagantishikha 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT woynaroskitiffanyg 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT cuttinglaurie 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT landmanbennett 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo AT casciocarissa 4420characterizingmedicalcomorbiditypriortoautismdiagnosisinchildrenbeforeagetwo |